 | • レポートコード：D0804-16066 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、129ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、片頭痛頭痛薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。片頭痛頭痛薬の種類別市場規模（アルモトリプタン、エレトリプタン、スマトリプタン、リザトリプタン、ゾルミトリプタン、ナラトリプタン、フロバトリプタン、その他）、用途別市場規模（急性片頭痛、一般片頭痛、古典片頭痛、慢性片頭痛、その他片頭痛）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、AstraZeneca、GSK、Novartis、Teva、Johnson & Johnson、Grunenthal、Eli Lilly、Merck、Sun Pharma、Apotex、Endo Pharmaceuticals、Ajanta Pharma、Amneal Pharmaceuticals、Mylan、Allergan、Bayer ・地域別グローバル市場分析 2015年-2020年 ・片頭痛頭痛薬の北米市場（アメリカ、カナダ、メキシコ） ・片頭痛頭痛薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・片頭痛頭痛薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・片頭痛頭痛薬の南米市場（ブラジル、アルゼンチン） ・片頭痛頭痛薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アルモトリプタン、エレトリプタン、スマトリプタン、リザトリプタン、ゾルミトリプタン、ナラトリプタン、フロバトリプタン、その他 ・用途別分析：急性片頭痛、一般片頭痛、古典片頭痛、慢性片頭痛、その他片頭痛 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Migraine Headache Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Migraine Headache Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Migraine Headache Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Migraine Headache Drugs market has been segmented into:
Almotriptan
Eletriptan
Sumatriptan
Rizatriptan
Zolmitriptan
Naratriptan
Frovatriptan
Others
By Application, Migraine Headache Drugs has been segmented into:
Acute Migraine
Common Migraine
Classic Migraine
Chronic Migraine
Other Migraines
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Migraine Headache Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Migraine Headache Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Migraine Headache Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Migraine Headache Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Migraine Headache Drugs Market Share Analysis
Migraine Headache Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Migraine Headache Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Migraine Headache Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Migraine Headache Drugs are:
Pfizer
AstraZeneca
GSK
Novartis
Teva
Johnson & Johnson
Grunenthal
Eli Lilly
Merck
Sun Pharma
Apotex
Endo Pharmaceuticals
Ajanta Pharma
Amneal Pharmaceuticals
Mylan
Allergan
Bayer
Table of Contents
1 Migraine Headache Drugs Market Overview
1.1 Product Overview and Scope of Migraine Headache Drugs
1.2 Classification of Migraine Headache Drugs by Type
1.2.1 Global Migraine Headache Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Migraine Headache Drugs Revenue Market Share by Type in 2019
1.2.3 Almotriptan
1.2.4 Eletriptan
1.2.5 Sumatriptan
1.2.6 Rizatriptan
1.2.7 Zolmitriptan
1.2.8 Naratriptan
1.2.9 Frovatriptan
1.2.10 Others
1.3 Global Migraine Headache Drugs Market by Application
1.3.1 Overview: Global Migraine Headache Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Acute Migraine
1.3.3 Common Migraine
1.3.4 Classic Migraine
1.3.5 Chronic Migraine
1.3.6 Other Migraines
1.4 Global Migraine Headache Drugs Market by Regions
1.4.1 Global Migraine Headache Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Migraine Headache Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Migraine Headache Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Migraine Headache Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Migraine Headache Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Migraine Headache Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Migraine Headache Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva SWOT Analysis
2.5.4 Teva Product and Services
2.5.5 Teva Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Grunenthal
2.7.1 Grunenthal Details
2.7.2 Grunenthal Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Grunenthal SWOT Analysis
2.7.4 Grunenthal Product and Services
2.7.5 Grunenthal Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck SWOT Analysis
2.9.4 Merck Product and Services
2.9.5 Merck Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sun Pharma SWOT Analysis
2.10.4 Sun Pharma Product and Services
2.10.5 Sun Pharma Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apotex SWOT Analysis
2.11.4 Apotex Product and Services
2.11.5 Apotex Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Endo Pharmaceuticals
2.12.1 Endo Pharmaceuticals Details
2.12.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Endo Pharmaceuticals SWOT Analysis
2.12.4 Endo Pharmaceuticals Product and Services
2.12.5 Endo Pharmaceuticals Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ajanta Pharma
2.13.1 Ajanta Pharma Details
2.13.2 Ajanta Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ajanta Pharma SWOT Analysis
2.13.4 Ajanta Pharma Product and Services
2.13.5 Ajanta Pharma Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Amneal Pharmaceuticals
2.14.1 Amneal Pharmaceuticals Details
2.14.2 Amneal Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Amneal Pharmaceuticals SWOT Analysis
2.14.4 Amneal Pharmaceuticals Product and Services
2.14.5 Amneal Pharmaceuticals Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 Mylan
2.15.1 Mylan Details
2.15.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Mylan SWOT Analysis
2.15.4 Mylan Product and Services
2.15.5 Mylan Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.16 Allergan
2.16.1 Allergan Details
2.16.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Allergan SWOT Analysis
2.16.4 Allergan Product and Services
2.16.5 Allergan Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bayer
2.17.1 Bayer Details
2.17.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bayer SWOT Analysis
2.17.4 Bayer Product and Services
2.17.5 Bayer Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Migraine Headache Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Migraine Headache Drugs Players Market Share
3.2.2 Top 10 Migraine Headache Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Migraine Headache Drugs Revenue and Market Share by Regions
4.2 North America Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
5 North America Migraine Headache Drugs Revenue by Countries
5.1 North America Migraine Headache Drugs Revenue by Countries (2015-2020)
5.2 USA Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
6 Europe Migraine Headache Drugs Revenue by Countries
6.1 Europe Migraine Headache Drugs Revenue by Countries (2015-2020)
6.2 Germany Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
6.4 France Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Migraine Headache Drugs Revenue by Countries
7.1 Asia-Pacific Migraine Headache Drugs Revenue by Countries (2015-2020)
7.2 China Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
7.5 India Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
8 South America Migraine Headache Drugs Revenue by Countries
8.1 South America Migraine Headache Drugs Revenue by Countries (2015-2020)
8.2 Brazil Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Migraine Headache Drugs by Countries
9.1 Middle East & Africa Migraine Headache Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Migraine Headache Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Migraine Headache Drugs Market Forecast by Type (2019-2024)
10.3 Almotriptan Revenue Growth Rate (2015-2025)
10.4 Eletriptan Revenue Growth Rate (2015-2025)
10.5 Sumatriptan Revenue Growth Rate (2015-2025)
10.6 Rizatriptan Revenue Growth Rate (2015-2025)
10.7 Zolmitriptan Revenue Growth Rate (2015-2025)
10.8 Naratriptan Revenue Growth Rate (2015-2025)
10.9 Frovatriptan Revenue Growth Rate (2015-2025)
10.10 Others Revenue Growth Rate (2015-2025)
11 Global Migraine Headache Drugs Market Segment by Application
11.1 Global Migraine Headache Drugs Revenue Market Share by Application (2015-2020)
11.2 Migraine Headache Drugs Market Forecast by Application (2019-2024)
11.3 Acute Migraine Revenue Growth (2015-2020)
11.4 Common Migraine Revenue Growth (2015-2020)
11.5 Classic Migraine Revenue Growth (2015-2020)
11.6 Chronic Migraine Revenue Growth (2015-2020)
11.7 Other Migraines Revenue Growth (2015-2020)
12 Global Migraine Headache Drugs Market Size Forecast (2021-2025)
12.1 Global Migraine Headache Drugs Market Size Forecast (2021-2025)
12.2 Global Migraine Headache Drugs Market Forecast by Regions (2021-2025)
12.3 North America Migraine Headache Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Migraine Headache Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Migraine Headache Drugs Revenue Market Forecast (2021-2025)
12.6 South America Migraine Headache Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Migraine Headache Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Migraine Headache Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Migraine Headache Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Migraine Headache Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Migraine Headache Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Migraine Headache Drugs Major Business
Table 7. Pfizer Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Migraine Headache Drugs Product and Solutions
Table 10. Pfizer Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AstraZeneca Corporate Information, Location and Competitors
Table 12. AstraZeneca Migraine Headache Drugs Major Business
Table 13. AstraZeneca Migraine Headache Drugs Total Revenue (USD Million) (2018-2019)
Table 14. AstraZeneca SWOT Analysis
Table 15. AstraZeneca Migraine Headache Drugs Product and Solutions
Table 16. AstraZeneca Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GSK Corporate Information, Location and Competitors
Table 18. GSK Migraine Headache Drugs Major Business
Table 19. GSK Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 20. GSK SWOT Analysis
Table 21. GSK Migraine Headache Drugs Product and Solutions
Table 22. GSK Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Migraine Headache Drugs Major Business
Table 25. Novartis Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Migraine Headache Drugs Product and Solutions
Table 28. Novartis Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Teva Corporate Information, Location and Competitors
Table 30. Teva Migraine Headache Drugs Major Business
Table 31. Teva Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Teva SWOT Analysis
Table 33. Teva Migraine Headache Drugs Product and Solutions
Table 34. Teva Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson & Johnson Corporate Information, Location and Competitors
Table 36. Johnson & Johnson Migraine Headache Drugs Major Business
Table 37. Johnson & Johnson Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Johnson & Johnson SWOT Analysis
Table 39. Johnson & Johnson Migraine Headache Drugs Product and Solutions
Table 40. Johnson & Johnson Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Grunenthal Corporate Information, Location and Competitors
Table 42. Grunenthal Migraine Headache Drugs Major Business
Table 43. Grunenthal Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Grunenthal SWOT Analysis
Table 45. Grunenthal Migraine Headache Drugs Product and Solutions
Table 46. Grunenthal Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly Corporate Information, Location and Competitors
Table 48. Eli Lilly Migraine Headache Drugs Major Business
Table 49. Eli Lilly Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Eli Lilly SWOT Analysis
Table 51. Eli Lilly Migraine Headache Drugs Product and Solutions
Table 52. Eli Lilly Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Merck Corporate Information, Location and Competitors
Table 54. Merck Migraine Headache Drugs Major Business
Table 55. Merck Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Merck SWOT Analysis
Table 57. Merck Migraine Headache Drugs Product and Solutions
Table 58. Merck Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sun Pharma Corporate Information, Location and Competitors
Table 60. Sun Pharma Migraine Headache Drugs Major Business
Table 61. Sun Pharma Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Sun Pharma SWOT Analysis
Table 63. Sun Pharma Migraine Headache Drugs Product and Solutions
Table 64. Sun Pharma Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Apotex Corporate Information, Location and Competitors
Table 66. Apotex Migraine Headache Drugs Major Business
Table 67. Apotex Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 68. Apotex SWOT Analysis
Table 69. Apotex Migraine Headache Drugs Product and Solutions
Table 70. Apotex Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Endo Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Endo Pharmaceuticals Migraine Headache Drugs Major Business
Table 73. Endo Pharmaceuticals Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 74. Endo Pharmaceuticals SWOT Analysis
Table 75. Endo Pharmaceuticals Migraine Headache Drugs Product and Solutions
Table 76. Endo Pharmaceuticals Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Ajanta Pharma Corporate Information, Location and Competitors
Table 78. Ajanta Pharma Migraine Headache Drugs Major Business
Table 79. Ajanta Pharma Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 80. Ajanta Pharma SWOT Analysis
Table 81. Ajanta Pharma Migraine Headache Drugs Product and Solutions
Table 82. Ajanta Pharma Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Amneal Pharmaceuticals Corporate Information, Location and Competitors
Table 84. Amneal Pharmaceuticals Migraine Headache Drugs Major Business
Table 85. Amneal Pharmaceuticals Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 86. Amneal Pharmaceuticals SWOT Analysis
Table 87. Amneal Pharmaceuticals Migraine Headache Drugs Product and Solutions
Table 88. Amneal Pharmaceuticals Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Mylan Corporate Information, Location and Competitors
Table 90. Mylan Migraine Headache Drugs Major Business
Table 91. Mylan Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 92. Mylan SWOT Analysis
Table 93. Mylan Migraine Headache Drugs Product and Solutions
Table 94. Mylan Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Allergan Corporate Information, Location and Competitors
Table 96. Allergan Migraine Headache Drugs Major Business
Table 97. Allergan Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 98. Allergan SWOT Analysis
Table 99. Allergan Migraine Headache Drugs Product and Solutions
Table 100. Allergan Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Bayer Corporate Information, Location and Competitors
Table 102. Bayer Migraine Headache Drugs Major Business
Table 103. Bayer Migraine Headache Drugs Total Revenue (USD Million) (2017-2018)
Table 104. Bayer SWOT Analysis
Table 105. Bayer Migraine Headache Drugs Product and Solutions
Table 106. Bayer Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Migraine Headache Drugs Revenue (Million USD) by Players (2015-2020)
Table 108. Global Migraine Headache Drugs Revenue Share by Players (2015-2020)
Table 109. Global Migraine Headache Drugs Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Migraine Headache Drugs Revenue Market Share by Regions (2015-2020)
Table 111. North America Migraine Headache Drugs Revenue by Countries (2015-2020)
Table 112. North America Migraine Headache Drugs Revenue Market Share by Countries (2015-2020)
Table 113. Europe Migraine Headache Drugs Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Migraine Headache Drugs Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Migraine Headache Drugs Revenue by Countries (2015-2020)
Table 116. South America Migraine Headache Drugs Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Migraine Headache Drugs Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Migraine Headache Drugs Revenue Market Share by Countries (2015-2020)
Table 119. Global Migraine Headache Drugs Revenue (Million USD) by Type (2015-2020)
Table 120. Global Migraine Headache Drugs Revenue Share by Type (2015-2020)
Table 121. Global Migraine Headache Drugs Revenue Forecast by Type (2021-2025)
Table 122. Global Migraine Headache Drugs Revenue by Application (2015-2020)
Table 123. Global Migraine Headache Drugs Revenue Share by Application (2015-2020)
Table 124. Global Migraine Headache Drugs Revenue Forecast by Application (2021-2025)
Table 125. Global Migraine Headache Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Migraine Headache Drugs Picture
Figure 2. Global Migraine Headache Drugs Revenue Market Share by Type in 2019
Figure 3. Almotriptan Picture
Figure 4. Eletriptan Picture
Figure 5. Sumatriptan Picture
Figure 6. Rizatriptan Picture
Figure 7. Zolmitriptan Picture
Figure 8. Naratriptan Picture
Figure 9. Frovatriptan Picture
Figure 10. Others Picture
Figure 11. Migraine Headache Drugs Revenue Market Share by Application in 2019
Figure 12. Acute Migraine Picture
Figure 13. Common Migraine Picture
Figure 14. Classic Migraine Picture
Figure 15. Chronic Migraine Picture
Figure 16. Other Migraines Picture
Figure 17. Global Migraine Headache Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. North America Migraine Headache Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Europe Migraine Headache Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Asia-Pacific Migraine Headache Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. South America Migraine Headache Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Middle East and Africa Migraine Headache Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Migraine Headache Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Migraine Headache Drugs Revenue Share by Players in 2019
Figure 25. Global Top 5 Players Migraine Headache Drugs Revenue Market Share in 2019
Figure 26. Global Top 10 Players Migraine Headache Drugs Revenue Market Share in 2019
Figure 27. Key Players Market Share Trend
Figure 28. Global Migraine Headache Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 29. Global Migraine Headache Drugs Revenue Market Share by Regions (2015-2020)
Figure 30. Global Migraine Headache Drugs Revenue Market Share by Regions in 2018
Figure 31. North America Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Europe Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Asia-Pacific Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 34. South America Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Middle East and Africa Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 36. North America Migraine Headache Drugs Revenue Market Share by Countries (2015-2020)
Figure 37. North America Migraine Headache Drugs Revenue Market Share by Countries in 2019
Figure 38. USA Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Canada Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Mexico Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Europe Migraine Headache Drugs Revenue Market Share by Countries (2015-2020)
Figure 42. Europe Migraine Headache Drugs Revenue Market Share by Countries in 2019
Figure 43. Germany Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 44. UK Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 45. France Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Russia Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Italy Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Migraine Headache Drugs Revenue Market Share by Countries (2015-2020)
Figure 49. Asia-Pacific Migraine Headache Drugs Revenue Market Share by Countries in 2019
Figure 50. China Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Japan Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Korea Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 53. India Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Southeast Asia Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 55. South America Migraine Headache Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. South America Migraine Headache Drugs Revenue Market Share by Countries in 2019
Figure 57. Brazil Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Argentina Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Middle East and Africa Migraine Headache Drugs Revenue Market Share by Countries (2015-2020)
Figure 60. Middle East and Africa Migraine Headache Drugs Revenue Market Share by Countries in 2019
Figure 61. Saudi Arabia Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 62. UAE Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 63. Egypt Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 64. South Africa Migraine Headache Drugs Revenue and Growth Rate (2015-2020)
Figure 65. Global Migraine Headache Drugs Revenue Share by Type (2015-2020)
Figure 66. Global Migraine Headache Drugs Revenue Share by Type in 2019
Figure 67. Global Migraine Headache Drugs Market Share Forecast by Type (2021-2025)
Figure 68. Global Almotriptan Revenue Growth Rate (2015-2020)
Figure 69. Global Eletriptan Revenue Growth Rate (2015-2020)
Figure 70. Global Sumatriptan Revenue Growth Rate (2015-2020)
Figure 71. Global Rizatriptan Revenue Growth Rate (2015-2020)
Figure 72. Global Zolmitriptan Revenue Growth Rate (2015-2020)
Figure 73. Global Naratriptan Revenue Growth Rate (2015-2020)
Figure 74. Global Frovatriptan Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Migraine Headache Drugs Revenue Share by Application (2015-2020)
Figure 77. Global Migraine Headache Drugs Revenue Share by Application in 2019
Figure 78. Global Migraine Headache Drugs Market Share Forecast by Application (2021-2025)
Figure 79. Global Acute Migraine Revenue Growth Rate (2015-2020)
Figure 80. Global Common Migraine Revenue Growth Rate (2015-2020)
Figure 81. Global Classic Migraine Revenue Growth Rate (2015-2020)
Figure 82. Global Chronic Migraine Revenue Growth Rate (2015-2020)
Figure 83. Global Other Migraines Revenue Growth Rate (2015-2020)
Figure 84. Global Migraine Headache Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 85. Global Migraine Headache Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 86. Global Migraine Headache Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 87. North America Migraine Headache Drugs Revenue Market Forecast (2021-2025)
Figure 88. Europe Migraine Headache Drugs Revenue Market Forecast (2021-2025)
Figure 89. Asia-Pacific Migraine Headache Drugs Revenue Market Forecast (2021-2025)
Figure 90. South America Migraine Headache Drugs Revenue Market Forecast (2021-2025)
Figure 91. Middle East and Africa Migraine Headache Drugs Revenue Market Forecast (2021-2025)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
デジタル片頭痛治療装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Digital Migraine Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…- 経口薄膜薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Thin Film Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2769.8 million by 2025, from USD 2033 million in 2019. The Oral Thin Film Dr…
- 血漿由来薬物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Plasma Derived Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasma Derived Drugs mar…
- 加齢性黄斑変性症（ARMD）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Age-relatedMacularDegeneration (ARMD) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 腎臓用治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Renal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…